Key result
Aortic valve repair shows comparable severe valve-related adverse events to replacement in multivalve rheumatic surgery.
Why the study?
The optimal management of aortic valve disease in patients with rheumatic heart disease undergoing multivalve surgery remains uncertain.
Does aortic valve repair compared to aortic valve replacement improve overall survival and freedom from valve-related events in patients with rheumatic heart disease undergoing multivalve surgery?
Cohort (n=288)
No
Does aortic valve repair compared to aortic valve replacement improve overall survival and freedom from valve-related events in patients with rheumatic heart disease undergoing multivalve surgery?
Absolute Event Rate: 8.2% vs 13.3%
p-value: p=0.21
Aortic valve repair provides comparable midterm survival and lower valve gradients compared to replacement in appropriately selected patients with rheumatic heart disease undergoing combined mitral and tricuspid procedures.
Supports repair as viable option in selected rheumatic multivalve cases; leaves open need for RCTs on long-term durability.
Objective: The management of aortic valve (AV) disease in patients with rheumatic heart disease (RHD) undergoing multivalve surgery remains uncertain. This study aimed to compare the long-term outcomes of AV repair versus AV replacement in patients with RHD undergoing combined mitral and tricuspid valve repair. Methods: We conducted a retrospective cohort study of 288 patients with RHD who underwent combined mitral and tricuspid valve repair with either AV repair (n = 122) or AV replacement (n = 166) at Beijing Anzhen Hospital from January 2015 to August 2024. The primary outcomes were overall survival and freedom from valve-related events. Kaplan-Meier survival analysis and inverse probability of treatment weighting were used to adjust for baseline differences and compare the groups. Results: = .21) between the 2 groups, with curves adjusted by inverse probability of treatment weighting showing consistent results. Conclusions: AV repair is a feasible and safe alternative to replacement in selected patients with RHD undergoing multivalve surgery, offering favorable early hemodynamics and comparable midterm outcomes.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) conducted a cohort in Rheumatic Heart Disease with moderate or severe aortic valve disease (n=288). Aortic valve repair vs. Aortic valve replacement was evaluated on Severe valve-related adverse events (p=0.21). In patients with rheumatic heart disease undergoing multivalve surgery, aortic valve repair was associated with comparable rates of severe valve-related adverse events (8.2% vs 13.3%) compared to aortic valve replacement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: